Andrew Berens
Stock Analyst at Leerink Partners
(4.86)
# 372
Out of 5,044 analysts
557
Total ratings
47.3%
Success rate
23.4%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $40 | $17.48 | +128.83% | 1 | Sep 21, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Rated: Buy | $27 → $25 | $3.31 | +655.29% | 5 | Sep 18, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $0.993 | +604.93% | 26 | Aug 7, 2026 | |
| EXEL Exelixis | Downgraded: Hold | $48 → $52 | $59.86 | -13.13% | 13 | Aug 6, 2026 | |
| INCY Incyte | Reiterated: Buy | $103 → $155 | $112.79 | +37.42% | 62 | Aug 3, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | n/a | $31.81 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $27.48 | +45.56% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $6.54 | - | 28 | Jun 2, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $46 → $51 | $21.08 | +141.94% | 2 | May 15, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 → $33 | $19.55 | +68.80% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $43 | $14.27 | +201.33% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $55 | $23.81 | +131.00% | 26 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $15.62 | +47.25% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.39 | +135.99% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $40 | $25.79 | +55.10% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $97 | $67.94 | +42.77% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $31.00 | +61.29% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $3.94 | +280.71% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $36.11 | -8.61% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.53 | n/a | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $2.41 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $17.88 | n/a | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.53 | n/a | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $7.64 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $354.47 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.64 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 | $7.89 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $0.38 | $0.365 | n/a | 25 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $167.47 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.57 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 → $25 | $3.16 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $15 | $10.30 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.00 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $10.29 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $90.78 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $8 | $7.54 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8011 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.89 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $38.42 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.50 | n/a | 2 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $151.17 | n/a | 3 | Dec 1, 2014 |
BlossomHill Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $40
Current: $17.48
Upside: +128.83%
BridgeBio Oncology Therapeutics
Sep 18, 2026
Rated: Buy
Price Target: $27 → $25
Current: $3.31
Upside: +655.29%
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $0.993
Upside: +604.93%
Exelixis
Aug 6, 2026
Downgraded: Hold
Price Target: $48 → $52
Current: $59.86
Upside: -13.13%
Incyte
Aug 3, 2026
Reiterated: Buy
Price Target: $103 → $155
Current: $112.79
Upside: +37.42%
Agios Pharmaceuticals
Jul 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.81
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $27.48
Upside: +45.56%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.54
Upside: -
Damora Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $46 → $51
Current: $21.08
Upside: +141.94%
Immunome
May 15, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $19.55
Upside: +68.80%
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $14.27
Upside: +201.33%
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $23.81
Upside: +131.00%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $15.62
Upside: +47.25%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.39
Upside: +135.99%
Nov 19, 2025
Reiterated: Buy
Price Target: $24 → $40
Current: $25.79
Upside: +55.10%
Nov 17, 2025
Reiterated: Buy
Price Target: $70 → $97
Current: $67.94
Upside: +42.77%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $31.00
Upside: +61.29%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $3.94
Upside: +280.71%
Oct 21, 2025
Reiterated: Hold
Price Target: $30 → $33
Current: $36.11
Upside: -8.61%
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.53
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $33
Current: $2.41
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $17.88
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $3
Current: $2.53
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $9
Current: $7.64
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $354.47
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $2.64
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $18.00
Current: $7.89
Upside: n/a
Jun 11, 2025
Reiterated: Hold
Price Target: $1 → $0.38
Current: $0.365
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $167.47
Upside: n/a
Dec 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $70.57
Upside: n/a
Feb 7, 2023
Reiterated: Buy
Price Target: $67 → $25
Current: $3.16
Upside: n/a
Feb 7, 2023
Reiterated: Hold
Price Target: $20 → $15
Current: $10.30
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: n/a
Current: $44.00
Upside: n/a
May 7, 2021
Reiterated: Hold
Price Target: $10
Current: $10.29
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Reiterated: Hold
Price Target: $23
Current: $90.78
Upside: n/a
Jul 14, 2017
Reiterated: Hold
Price Target: $16 → $8
Current: $7.54
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.8011
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $7.89
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $38.42
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $12.50
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $151.17
Upside: n/a